 |
| PDB ID: 6y2e Macromolecule: REPLICASE POLYPROTEIN 1AB Source Organism: SARS-CoV-2 Gene names: 1a-1brep UniProt ID: P0DTD1 |
SIMILAR PATTERN OF AMINO ACIDS MAPPED TO PDBID '6y2e'
1) User may click on the DrReposER ID (the first column) to get information on the binding sites and drug molecule.2) Click View (the second last column) to view matched residues and superposition in the NGL viewer (upper right part).3) User may also click on the Dock (the last column) to get script for molecular docking in UCSF Chimera through AutoDock Vina.| DrReposER ID / Desc. | Drug | Res. Matches |
View | Interface | RMSD | Seq. Identity (%) |
HETATM | Dock | |
|---|---|---|---|---|---|---|---|---|---|
 Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4LMN_A_EUIA503_1 (DUAL SPECIFICITYMITOGEN-ACTIVATEDPROTEIN KINASEKINASE 1) | Cobimetinib | 5 / 12 | LEU A 208LEU A 287ILE A 281ASN A 277SER A 267 | 1.36A | 20.82 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3A51_E_VDYE6178_1 (VITAMIN DHYDROXYLASE) | Calcidiol | 5 / 12 | ASN A 214ILE A 259ALA A 260VAL A 247LEU A 250 | 1.42A | 20.79 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5HIE_B_P06B801_1 (SERINE/THREONINE-PROTEIN KINASE B-RAF) | Dabrafenib | 5 / 12 | VAL A 125ALA A 7PHE A 140PHE A 150GLY A 149 | 1.39A | 20.74 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4O8F_A_BRLA501_2 (PEROXISOMEPROLIFERATOR-ACTIVATED RECEPTOR GAMMA) | Rosiglitazone | 4 / 5 | GLY A 23LEU A 27ILE A 43LEU A 89 | 1.00A | 21.86 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2LBD_A_REAA500_1 (RETINOIC ACIDRECEPTOR GAMMA) | Tretinoin | 5 / 12 | LEU A 287ILE A 281ARG A 279PHE A 219LEU A 250 | 1.53A | 21.01 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4A99_D_MIYD393_1 (TETX2 PROTEIN) | Minocycline | 4 / 5 | ILE A 106GLN A 110ILE A 200GLU A 290 | 1.61A | 23.29 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3L4D_D_TPFD490_1 (STEROL 14-ALPHADEMETHYLASE) | Fluconazole | 4 / 8 | ALA A 193ALA A 194THR A 135MET A 165 | 1.05A | 21.88 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4X1I_D_LOCD502_1 (TUBULIN BETA CHAIN) | Colchicine | 5 / 12 | LEU A 287LEU A 208LEU A 271ASN A 221ALA A 211 | 1.39A | 20.43 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1UPF_B_URFB999_1 (URACILPHOSPHORIBOSYLTRANSFERASE) | Fluorouracil | 5 / 7 | MET A 130ALA A 129ILE A 136ASP A 197PHE A 134 | 1.74A | 19.53 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1JHQ_A_NIOA991_1 (NICOTINATEMONONUCLEOTIDE:5,6-DIMETHYLBENZIMIDAZOLEPHOSPHORIBOSYLTRANSFERASE) | Niacin | 5 / 8 | THR A 26GLY A 146LEU A 27SER A 147GLY A 29 | 1.54A | 21.64 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4UCK_A_SAMA2409_0 (RNA-DIRECTED RNAPOLYMERASE L) | S-Adenosylmethionine | 5 / 12 | THR A 26GLY A 146GLY A 29GLY A 120THR A 175 | 1.39A | 21.76 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1JHV_A_NIOA991_1 (NICOTINATEMONONUCLEOTIDE:5,6-DIMETHYLBENZIMIDAZOLEPHOSPHORIBOSYLTRANSFERASE) | Niacin | 5 / 8 | THR A 26GLY A 146LEU A 27SER A 147GLY A 29 | 1.53A | 21.64 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6HU9_H_PCFH604_0 (CYTOCHROME B-C1COMPLEX SUBUNIT 8CYTOCHROME C OXIDASEPOLYPEPTIDE 5A,MITOCHONDRIAL) | Colfosceril palmitate | 5 / 8 | GLY A 174HIS A 163VAL A 171GLY A 149ALA A 129 | 1.67A | 14.9216.45 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1JHO_A_NIOA991_1 (NICOTINATEMONONUCLEOTIDE:5,6-DIMETHYLBENZIMIDAZOLEPHOSPHORIBOSYLTRANSFERASE) | Niacin | 5 / 9 | THR A 26GLY A 146LEU A 27SER A 147GLY A 29 | 1.52A | 21.64 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6HCO_A_FY5A1003_0 (ATP-BINDING CASSETTESUB-FAMILY G MEMBER2) | Estrone sulfate | 5 / 11 | PHE A 294VAL A 303PHE A 8THR A 111ILE A 106 | 1.73A | 18.20 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3BJM_B_BJMB2_1 (DIPEPTIDYL PEPTIDASE4) | Saxagliptin | 5 / 12 | ARG A 298PHE A 291SER A 113VAL A 114ASN A 151 | 1.56A | 16.14 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5IKT_B_TLFB601_0 (PROSTAGLANDIN G/HSYNTHASE 2) | Tolfenamic Acid | 5 / 12 | VAL A 73VAL A 91LEU A 89VAL A 20GLY A 29 | 1.49A | 19.48 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3HEG_A_BAXA1_1 (MITOGEN-ACTIVATEDPROTEIN KINASE 14) | Sorafenib | 5 / 12 | VAL A 297VAL A 296ALA A 206GLU A 290ILE A 200 | 1.52A | 19.17 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5GTR_A_ESTA601_1 (ESTROGEN RECEPTOR) | Estradiol | 5 / 12 | LEU A 282ALA A 210MET A 264ILE A 259LEU A 253 | 1.39A | 21.78 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3MBH_B_PXLB400_1 (PUTATIVEPHOSPHOMETHYLPYRIMIDINE KINASE) | Pyridoxal | 5 / 12 | VAL A 212THR A 257GLN A 256TYR A 209VAL A 296 | 1.78A | 21.89 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4ACB_B_DXCB1473_0 (TRANSLATIONELONGATION FACTORSELB) | Deoxycholic Acid | 4 / 8 | ILE A 136GLY A 138GLN A 127ARG A 298 | 0.91A | 20.36 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3ASN_B_CHDB1085_0 (CYTOCHROME C OXIDASESUBUNIT 1CYTOCHROME C OXIDASESUBUNIT 2CYTOCHROME C OXIDASESUBUNIT 6A2) | Cholic Acid | 5 / 11 | MET A 17GLY A 29GLN A 19THR A 21GLY A 143 | 1.65A | 20.0820.1313.31 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3KEE_D_30BD500_1 (GENOME POLYPROTEIN) | Simeprevir | 5 / 12 | GLY A 138GLY A 170ARG A 131ALA A 194ASP A 197 | 1.24A | 23.55 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3UE4_B_DB8B601_1 (TYROSINE-PROTEINKINASE ABL1) | Bosutinib | 5 / 12 | LEU A 30VAL A 36GLY A 146LEU A 27PHE A 66 | 1.16A | 22.12 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5F9Z_A_HFGA702_0 (AMINOACYL-TRNASYNTHETASE) | Halofuginone | 5 / 12 | LEU A 177GLY A 174VAL A 86PHE A 140GLY A 143 | 1.49A | 20.12 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1QZZ_A_ACTA421_0 (ACLACINOMYCIN-10-HYDROXYLASE) | Acetic acid | 5 / 8 | TYR A 118GLY A 146GLY A 143LEU A 27SER A 147 | 1.68A | 22.28 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4U5J_B_RXTB601_1 (PROTO-ONCOGENETYROSINE-PROTEINKINASE SRC) | Ruxolitinib | 5 / 9 | LEU A 250VAL A 202ALA A 206TYR A 209LEU A 268 | 1.78A | 23.62 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1A4L_A_DCFA353_2 (ADENOSINE DEAMINASE) | Pentostatin | 4 / 5 | LEU A 32LEU A 30SER A 10LEU A 115 | 1.21A | 21.39 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1XWF_A_ADNA433_1 (ADENOSYLHOMOCYSTEINASE) | Adenosine | 5 / 12 | LEU A 27THR A 25ASP A 187LEU A 58MET A 49 | 1.59A | 21.59 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3KEE_A_30BA500_1 (GENOME POLYPROTEIN) | Simeprevir | 5 / 12 | GLY A 138GLY A 170ARG A 131ALA A 194ASP A 197 | 1.20A | 23.55 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1L4N_A_NIOA991_1 (NICOTINATE-NUCLEOTIDE--DIMETHYLBENZIMIDAZOLEPHOSPHORIBOSYLTRANSFERASE) | Niacin | 5 / 9 | THR A 26GLY A 146LEU A 27SER A 147GLY A 29 | 1.54A | 21.64 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6BEH_A_RPTA601_1 (SCAFFOLD PROTEIN D13) | Rifapentine | 5 / 10 | GLU A 290VAL A 157PHE A 140PHE A 8PHE A 150 | 1.62A | 22.06 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1L5L_A_NIOA991_1 (NICOTINATE-NUCLEOTIDE--DIMETHYLBENZIMIDAZOLEPHOSPHORIBOSYLTRANSFERASE) | Niacin | 5 / 9 | THR A 26GLY A 146LEU A 27SER A 147GLY A 29 | 1.54A | 21.64 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5C0O_H_SAMH301_1 (TRNA(ADENINE(58)-N(1))-METHYLTRANSFERASETRMI) | S-Adenosylmethionine | 4 / 5 | THR A 111GLY A 109GLU A 288ASP A 295 | 1.66A | 22.73 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1XOS_A_VIAA1_1 (CAMP-SPECIFIC3',5'-CYCLICPHOSPHODIESTERASE 4B) | Sildenafil | 5 / 12 | PHE A 294SER A 301GLN A 127PHE A 8ILE A 152 | 1.61A | 21.84 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1TT0_A_ACTA4901_0 (PYRANOSE OXIDASE) | Acetic acid | 4 / 6 | THR A 292GLN A 127PHE A 8ASN A 151 | 1.65A | 18.49 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3ELZ_A_CHDA150_0 (ILEAL BILEACID-BINDING PROTEIN) | Cholic Acid | 5 / 12 | GLN A 127ASN A 151PHE A 150VAL A 148LEU A 115 | 1.65A | 20.13 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2ZJ0_A_2FAA500_2 (ADENOSYLHOMOCYSTEINASE) | Fludarabine | 4 / 5 | GLN A 110THR A 111THR A 201LEU A 250 | 1.20A | 19.88 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6BED_C_RFPC601_1 (SCAFFOLD PROTEIN D13) | Rifampicin | 5 / 11 | GLU A 290VAL A 157PHE A 140GLN A 110PHE A 8 | 1.45A | 22.06 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2AA5_A_STRA301_1 (MINERALOCORTICOIDRECEPTOR) | Progesterone | 5 / 12 | ASN A 28LEU A 115ALA A 116SER A 123THR A 26 | 1.70A | 23.01 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1ZQ9_B_SAMB4001_0 (PROBABLEDIMETHYLADENOSINETRANSFERASE) | S-Adenosylmethionine | 6 / 12 | LEU A 287VAL A 212ASN A 221LEU A 220ILE A 259PHE A 223 | 1.77A | 20.19 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4KQI_A_NIOA403_1 (NICOTINATE-NUCLEOTIDE--DIMETHYLBENZIMIDAZOLEPHOSPHORIBOSYLTRANSFERASE) | Niacin | 5 / 9 | THR A 26GLY A 146LEU A 27SER A 147GLY A 29 | 1.49A | 21.64 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5I73_A_68PA701_1 (SODIUM-DEPENDENTSEROTONINTRANSPORTER) | Citalopram | 6 / 12 | ALA A 173TYR A 182PHE A 140LEU A 167GLY A 149VAL A 114 | 1.76A | 20.58 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5UHG_C_RFPC1201_1 (DNA-DIRECTED RNAPOLYMERASE SUBUNITBETA) | Rifampicin | 5 / 12 | ASP A 187HIS A 41ARG A 60ILE A 43ARG A 40 | 1.44A | 15.60 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5YK2_A_ERYA501_0 (PROBABLE CONSERVEDATP-BINDING PROTEINABC TRANSPORTER) | Erythromycin | 5 / 11 | GLU A 288ALA A 210ALA A 206ARG A 298VAL A 297 | 1.50A | 23.06 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4F4D_B_CHDB503_0 (FERROCHELATASE,MITOCHONDRIAL) | Cholic Acid | 4 / 8 | ILE A 152ARG A 298PRO A 122VAL A 114 | 1.56A | 21.28 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2R5P_B_MK1B902_1 (PROTEASE) | Indinavir | 6 / 12 | ASP A 295ASP A 289VAL A 202ILE A 200GLY A 109ILE A 106 | 1.78A | 16.43 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3HLW_B_CE3B302_2 (CTX-M-9EXTENDED-SPECTRUMBETA-LACTAMASE) | Cefotaxime | 3 / 3 | CYH A 16PRO A 96ASP A 33 | 1.78A | 20.63 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3R0L_D_ACTD127_0 (PHOSPHOLIPASE A2 CB) | Acetic acid | 4 / 5 | PHE A 140ILE A 136GLY A 149HIS A 163 | 1.75A | 17.26 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4ZPH_A_PRLA501_0 (ARYL HYDROCARBONRECEPTOR NUCLEARTRANSLOCATORENDOTHELIAL PASDOMAIN-CONTAININGPROTEIN 1) | Proflavine | 4 / 7 | ARG A 217VAL A 212TRP A 218LEU A 220 | 1.38A | 19.7522.45 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3UCJ_A_AZMA229_1 (CARBONIC ANHYDRASE) | Acetazolamide | 5 / 10 | ASP A 197GLY A 195ALA A 194ALA A 193THR A 169 | 1.41A | 21.02 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3MNP_A_DEXA784_1 (GLUCOCORTICOIDRECEPTOR) | Betamethasone | 5 / 12 | ASN A 231VAL A 204LEU A 268CYH A 265THR A 225 | 1.67A | 22.15 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3L4D_A_TPFA490_1 (STEROL 14-ALPHADEMETHYLASE) | Fluconazole | 4 / 8 | ALA A 193ALA A 194THR A 135MET A 165 | 1.06A | 21.88 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2X9G_A_LYAA1270_2 (PTERIDINE REDUCTASE) | Pemetrexed | 3 / 3 | MET A 6VAL A 157GLU A 14 | 1.45A | 23.03 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3OXW_B_017B200_2 (HIV-1 PROTEASE) | Darunavir | 5 / 10 | ASP A 176VAL A 104GLY A 149VAL A 114ILE A 106 | 1.48A | 17.83 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3CE6_A_ADNA500_2 (ADENOSYLHOMOCYSTEINASE) | Adenosine | 4 / 5 | GLN A 110THR A 111THR A 201LEU A 250 | 1.28A | 19.92 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1JHY_A_NIOA991_1 (NICOTINATEMONONUCLEOTIDE:5,6-DIMETHYLBENZIMIDAZOLEPHOSPHORIBOSYLTRANSFERASE) | Niacin | 5 / 9 | THR A 26GLY A 146LEU A 27SER A 147GLY A 29 | 1.53A | 21.64 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2QD3_A_CHDA502_0 (FERROCHELATASE) | Cholic Acid | 4 / 8 | PRO A 122SER A 121VAL A 13GLY A 15 | 1.63A | 21.28 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5I75_A_68PA701_1 (SODIUM-DEPENDENTSEROTONINTRANSPORTER) | Citalopram | 6 / 12 | ALA A 173TYR A 182PHE A 140LEU A 167GLY A 149VAL A 114 | 1.75A | 20.58 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1L5K_A_NIOA991_1 (NICOTINATE-NUCLEOTIDE--DIMETHYLBENZIMIDAZOLEPHOSPHORIBOSYLTRANSFERASE) | Niacin | 5 / 9 | THR A 26GLY A 146LEU A 27SER A 147GLY A 29 | 1.53A | 21.64 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1CBS_A_REAA200_1 (CELLULAR RETINOICACID BINDING PROTEINTYPE II) | Tretinoin | 5 / 12 | LEU A 167ILE A 136ALA A 173THR A 175TYR A 54 | 1.29A | 19.61 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5I71_A_68PA701_1 (SODIUM-DEPENDENTSEROTONINTRANSPORTER) | Citalopram | 6 / 12 | ALA A 173TYR A 182PHE A 140LEU A 167GLY A 149VAL A 114 | 1.73A | 20.58 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2OAX_D_SNLD4001_2 (MINERALOCORTICOIDRECEPTOR) | Spironolactone | 4 / 5 | LEU A 87LEU A 57CYH A 85THR A 175 | 1.75A | 22.60 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5L5F_H_BO2H301_1 (PROTEASOME SUBUNITBETA TYPE-2PROTEASOME SUBUNITBETA TYPE-3) | Bortezomib | 5 / 12 | CYH A 128ALA A 173GLY A 174THR A 175CYH A 160 | 1.61A | 19.6921.82 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2AA5_B_STRB302_1 (MINERALOCORTICOIDRECEPTOR) | Progesterone | 5 / 12 | ASN A 28LEU A 115ALA A 116SER A 123THR A 26 | 1.71A | 23.01 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5M0I_B_ACTB303_0 (SWI5-DEPENDENT HOEXPRESSION PROTEIN 2) | Acetic acid | 4 / 5 | VAL A 171THR A 135ASN A 133ASP A 197 | 1.53A | 23.15 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1JHA_A_NIOA991_1 (NICOTINATEMONONUCLEOTIDE:5,6-DIMETHYLBENZIMIDAZOLEPHOSPHORIBOSYLTRANSFERASE) | Niacin | 5 / 8 | THR A 26GLY A 146LEU A 27SER A 147GLY A 29 | 1.50A | 21.64 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1D4F_B_ADNB602_2 (S-ADENOSYLHOMOCYSTEINE HYDROLASE) | Adenosine | 4 / 5 | THR A 198THR A 199THR A 292HIS A 246 | 1.49A | 21.36 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2VMY_B_GLYB502_0 (SERINEHYDROXYMETHYLTRANSFERASE) | Glycine | 4 / 8 | TYR A 126SER A 139HIS A 163SER A 144 | 1.47A | 21.55 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3OND_A_ADNA506_2 (ADENOSYLHOMOCYSTEINASE) | Adenosine | 3 / 3 | GLN A 110THR A 111LEU A 250 | 0.68A | 20.52 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1D0V_A_NIOA991_1 (NICOTINATEMONONUCLEOTIDE:5,6-DIMETHYLBENZIMIDAZOLEPHOSPHORIBOSYLTRANSFERASE) | Niacin | 5 / 8 | THR A 26GLY A 146LEU A 27SER A 147GLY A 29 | 1.52A | 21.64 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1JHR_A_NIOA991_1 (NICOTINATEMONONUCLEOTIDE:5,6-DIMETHYLBENZIMIDAZOLEPHOSPHORIBOSYLTRANSFERASE) | Niacin | 5 / 9 | THR A 26GLY A 146LEU A 27SER A 147GLY A 29 | 1.52A | 21.64 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1L5M_A_NIOA991_1 (NICOTINATE-NUCLEOTIDE--DIMETHYLBENZIMIDAZOLEPHOSPHORIBOSYLTRANSFERASE) | Niacin | 5 / 9 | THR A 26GLY A 146LEU A 27SER A 147GLY A 29 | 1.54A | 21.64 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1V54_B_CHDB4085_0 (CYTOCHROME C OXIDASEPOLYPEPTIDE ICYTOCHROME C OXIDASEPOLYPEPTIDE IICYTOCHROME C OXIDASEPOLYPEPTIDEVIA-HEART) | Cholic Acid | 5 / 11 | MET A 17GLY A 29GLN A 19THR A 21GLY A 143 | 1.61A | 20.0820.1313.31 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5MO4_A_NILA601_2 (TYROSINE-PROTEINKINASE ABL1) | Nilotinib | 6 / 12 | VAL A 296ILE A 213VAL A 212ILE A 259PHE A 3LEU A 220 | 1.74A | 21.98 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3FXR_A_ASCA3001_0 (LYSR TYPE REGULATOROF TSAMBCD) | Vitamin C | 4 / 8 | ARG A 298ILE A 152ASN A 151PRO A 9 | 1.35A | 19.59 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4G5J_A_0WMA1103_1 (EPIDERMAL GROWTHFACTOR RECEPTOR) | Afatinib | 4 / 5 | ASN A 65ARG A 60HIS A 80LEU A 87 | 1.79A | 21.74 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1Q23_E_FUAE706_1 (CHLORAMPHENICOLACETYLTRANSFERASE) | Fusidic Acid | 5 / 10 | THR A 111PHE A 8PHE A 3VAL A 303PHE A 305 | 1.68A | 23.48 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5YW0_A_ACTA411_0 (UNCHARACTERIZEDPROTEIN KDOO) | Acetic acid | 3 / 3 | LYS A 61LEU A 57ARG A 60 | 1.57A | 24.71 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1A4L_C_DCFC1353_2 (ADENOSINE DEAMINASE) | Pentostatin | 4 / 5 | LEU A 32LEU A 30SER A 10LEU A 115 | 1.26A | 21.39 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3KEE_C_30BC500_1 (GENOME POLYPROTEIN) | Simeprevir | 5 / 12 | GLY A 138GLY A 170ARG A 131ALA A 194ASP A 197 | 1.24A | 23.55 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2FR3_A_REAA300_1 (CELLULAR RETINOICACID BINDING PROTEIN2) | Tretinoin | 5 / 12 | LEU A 167ILE A 136ALA A 173THR A 175TYR A 54 | 1.28A | 19.61 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5ECL_A_ILEA602_0 (JASMONIC ACID-AMIDOSYNTHETASE JAR1) | L-Isoleucine | 4 / 6 | ALA A 94THR A 93VAL A 91VAL A 73 | 1.47A | 20.00 | None |